MEI Pharma (MEIP) Reports Q3 Net Loss $21.5M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. META
5. SPY
6. ANT
7. INTC
8. JBLU
9. NVDA
10. AAPL

Go back to MEI Pharma (MEIP) Reports Q3 Net Loss $21.5M

 MEI Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlights

May 23, 2022 4:20 PM EDT

 --MEI Begins Fourth Fiscal Quarter with $169.0 Million in Cash--

SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for the quarter ended March 31, 2022, and highlighted recent corporate events.

The third fiscal quarter of 2022 was underscored by a meeting with the FDA in which we were informed that data from randomized studies are now needed to adequately assess the benefit-risk of PI3K inhibitor drug candidates, including zandelisib, and where it was emphasized that we should... More